Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 7Colorectal Neoplasms 4Polyps 3Gastroesophageal Reflux 3Esophageal Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Hyperplasia 2Adenomatous Polyposis Coli 2Adenocarcinoma 2Upper Tract Urothelial Carcinoma 1Stomach Ulcer 1Stomach Diseases 1Squamous Cell Carcinoma of Head and Neck 1Polyposis, Gastric 1Pancreatic Pseudocyst 1Neoplasms 1Lung Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Fistula 1Esophagitis, Peptic 1Esophageal and Gastric Varices 1ENDOSCOPIC CHARACTERIZATION 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Carcinoma 1Anastomotic Leak 1Adenomatous Polyps 1Adenoma 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1Restraint, Physical 1Microspheres 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hyperplasia × Endoscopy × Clear all
NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡